Brief: Qualigen Therapeutics On Feb 15, Entered Into License And Sublicense Agreement With Pan-Ras Holdings
22/02/2024 23:26
Feb 22 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS INC - ON FEB 15, 2024, ENTERED INTO
LICENSE AND SUBLICENSE AGREEMENT WITH PAN-RAS HOLDINGS
* QUALIGEN THERAPEUTICS - PAN-RAS HAS RIGHT TO TERMINATE
LICENSE &
SUBLICENSE AGREEMENT ON OR BEFORE MARCH 16
Source text for Eikon: ID:n0001493152-24-007562
Further company coverage: QLGN.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise